(Q34134867)

31 July 2017

1 reference

title

New trends in immunotherapy to prevent atopic diseases (English)

1 reference

31 July 2017

1 reference

Walker C

1

1 reference

31 July 2017

Zuany-Amorim C

series ordinal

2

1 reference

31 July 2017

publication date

1 February 2001

1 reference

Trends in Pharmacological Sciences

31 July 2017

published in

1 reference

31 July 2017

volume

22

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

84-90

1 reference

TH2 and 'TH2-like' cells in allergy and asthma: pharmacological perspectives

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Induction and regulation of the IgE response

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Molecular mechanisms of IgE regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

The role of allergy in the development of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Genetic 'risk' for atopy is associated with delayed postnatal maturation of T-cell competence

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Interleukin-4 is required for the induction of lung Th2 mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Effects of an antibody to interleukin-5 in a monkey model of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Long-term clinical efficacy of grass-pollen immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Allergen immunotherapy: therapeutic vaccines for allergic diseases. Geneva: January 27-29 1997

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

The consideration of immunotherapy in the treatment of allergic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Immunologic changes associated with allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Recombinant allergens

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Treatment of allergic airways disease with anti-IgE

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

The pharmacological basis of anti-IgE therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Pretreatment with allergen prevents immediate hypersensitivity and airway hyperresponsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Treatment of cat allergy with T-cell reactive peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Peptide modulation of allergen-specific immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Modulation of Th2 responses by peptide analogues in a murine model of allergic asthma: amelioration or deterioration of the disease process depends on the Th1 or Th2 skewing characteristics of the therapeutic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

DNA immunization: a novel approach to allergen-specific immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Immune responses to DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Could the risk of asthma and atopy be reduced by a vaccine that induces a strong T-helper type 1 response?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

The inverse association between tuberculin responses and atopic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Causing a commotion in the blood: immunotherapy progresses from bacteria to bacterial DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

Could asthma be worsened by stimulating the T-helper type 1 immune response?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901633-3

7 January 2021

10.1016/S0165-6147(00)01633-3

Identifiers

DOI

1 reference

31 July 2017

1 reference